Pursuant to Reg 30 & 47 of SEBI (LODR), 2015, Submission of Newspaper advertisement of Unaudited Financial Results for the Quarter and half year ended 30.09.2024.

pdf

ANG Lifesciences India Ltd.

14 Nov 2024

28.86

4.53%

Result

ANG Lifesciences India Ltd - 540694 - Financial Results For Quarter And Half Year Ended 30.09.2024.

BSE India

Financial Results for Quarter and Half year ended 30.09.2024.

pdf

ANG Lifesciences India Ltd.

14 Nov 2024

28.86

4.53%

Board Meeting

ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of The Board Meeting …

BSE India

Pursuant to Regulation 30 of SEBI (LODR), 2015, enclosed are the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended 30.09.2024.

pdf

ANG Lifesciences India Ltd.

07 Nov 2024, 05:02PM

28.86

4.53%

Board Meeting

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant …

BSE India

ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve 1. To consider and approve the Unaudited Standalone & Consolidated Financial Results along with Limited Review Report thereon for the Quarter and Half year ended 30th September, 2024. 2. Transact any other matter, if any with permission of chairman. Pursuant to the SEBI [Prohibition of Insider Trading] Regulation and policy on Code of conduct for prevention of Insider Trading and Fair Disclosure of Unpublished Price Sensitive Information of the Company, the Trading Window stands closed from 01st October, 2024 and will end on 48 hours after the results are made public on 14th November, 2024.

pdf